Circulating tumor DNA: a revolutionary approach for early detection and personalized treatment of bladder cancer
Bladder cancer is a malignant tumor with a high global incidence and recurrence rate. Traditional diagnostic methods, such as cystoscopy and urine cytology, have limitations in sensitivity and specificity, particularly in detecting low-grade bladder cancer. Circulating tumor DNA (ctDNA) offers a non...
Saved in:
| Main Authors: | Yan Zhou, Rongzhong Wang, Mingtang Zeng, Sijia Liu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-03-01
|
| Series: | Frontiers in Pharmacology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2025.1551219/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Utility and Clinical Application of Circulating Tumor DNA (ctDNA) in Advanced Prostate Cancer
by: Louise Kostos, et al.
Published: (2023-07-01) -
The development and applications of circulating tumour cells, circulating tumour DNA and other emerging biomarkers for early cancer detection
by: David Sinclair Thomas Junior, et al.
Published: (2025-05-01) -
Circulating tumor DNA in colorectal cancer: biology, methods and applications
by: Han Chen, et al.
Published: (2025-04-01) -
Detection of a novel DNA methylation marker panel for esophageal cancer diagnosis using circulating tumor DNA
by: Yan Zheng, et al.
Published: (2024-12-01) -
Circulating tumor DNA in cholangiocarcinoma: current clinical applications and future perspectives
by: Yi Wang, et al.
Published: (2025-07-01)